Colon cancers displaying microsatellite instability (MSI) are clinically less aggressive. Based on in vitro studies and recent clinical data, cancers displaying MSI do not respond to 5-fluorouracil (5-FU). The reasons why MSI tumors are clinically less aggressive and do not respond to 5-FU-based therapies have not been fully elucidated. PURPOSE: We investigated biomolecular markers in an attempt to explain the different clinical behavior and chemotherapeutic responses of MSI and non-MSI colon cancers. EXPERIMENTAL DESIGN: One hundred ninety-two sporadic colon cancers were tested for MSI with five mononucleotide markers and methylation of the hMLH1 promoter. Slides were stained for thymidylate synthase (TS), p53, MDM2, p21(WAF1/CIP1), be...
BACKGROUND: Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological feature...
High frequency microsatellite instability (MSI—H) is an alternate pathway of colorectal carcinogene...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...
Colon cancers displaying microsatellite instability (MSI) are clinically less aggressive. Based on i...
Colon cancers displaying microsatellite instability (MSI) are clinically less aggressive. Based on i...
Abstract Background Microsatellite instability (MSI) refers to mutations in short motifs of tandemly...
BACKGROUND: 5-Fluorouracil (5-FU) is the most commonly used therapeutic agent for colon cancer treat...
5-Fluorouracil (5FU) is the main drug used for the treatment of colorectal cancer (CRC) and Thymidil...
5-Fluorouracil (5FU) is the main drug used for the treatment of colorectal cancer (CRC) and Thymidil...
Recent clinical studies have reported that microsatellite instability (MSI) colorectal cancers show ...
Abstract BACKGROUND: Microsatellite instability (MSI) is a biological characteristic of most tumou...
BACKGROUND: Microsatellite instability (MSI) is a distinct molecular phenotype of colorectal cancer ...
Abstract BACKGROUND: Microsatellite instability (MSI) is a biological characteristic of most tumours...
BACKGROUND: Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological features,...
The influence of MSI on treatment outcome of colorectal cancers re mains unclear and deserves furthe...
BACKGROUND: Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological feature...
High frequency microsatellite instability (MSI—H) is an alternate pathway of colorectal carcinogene...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...
Colon cancers displaying microsatellite instability (MSI) are clinically less aggressive. Based on i...
Colon cancers displaying microsatellite instability (MSI) are clinically less aggressive. Based on i...
Abstract Background Microsatellite instability (MSI) refers to mutations in short motifs of tandemly...
BACKGROUND: 5-Fluorouracil (5-FU) is the most commonly used therapeutic agent for colon cancer treat...
5-Fluorouracil (5FU) is the main drug used for the treatment of colorectal cancer (CRC) and Thymidil...
5-Fluorouracil (5FU) is the main drug used for the treatment of colorectal cancer (CRC) and Thymidil...
Recent clinical studies have reported that microsatellite instability (MSI) colorectal cancers show ...
Abstract BACKGROUND: Microsatellite instability (MSI) is a biological characteristic of most tumou...
BACKGROUND: Microsatellite instability (MSI) is a distinct molecular phenotype of colorectal cancer ...
Abstract BACKGROUND: Microsatellite instability (MSI) is a biological characteristic of most tumours...
BACKGROUND: Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological features,...
The influence of MSI on treatment outcome of colorectal cancers re mains unclear and deserves furthe...
BACKGROUND: Mucinous colorectal cancer (CRC) exhibits distinct clinical and pathological feature...
High frequency microsatellite instability (MSI—H) is an alternate pathway of colorectal carcinogene...
Microsatellite instability (MSI), the molecular phenotype of colorectal cancers with mismatch repair...